Sign in

NCT03856879Completed

High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults

AdvanCing High-quality COPD Care for People With Immune Dysfunction by Implementing EVidence-based Management Through Proactive E-consults

Source: ClinicalTrials.gov · Last updated 30 Jul 2025

Brief summary (registry, in English)

This study examines an intervention to promote effective, evidence-based care and de-implement inappropriate therapies for COPD in HIV-infected (HIV+) patients. The intervention facilitates specialist support of primary care, which includes infectious disease (ID) physicians who serve as the primary care providers (PCP) for their HIV+ patients in the ID clinic. Rather than relying on referral-driven specialty care which may be a barrier to access, pulmonologists will proactively support ID providers to manage a population of HIV+ patients with COPD, delivering real-time evidence-based recommendations tailored to the individual HIV+ patient in the form of an E-consult.

Status (registry)
Completed
Study type
Interventional
Enrollment
270 (actual)
First submitted
20 Feb 2019
Start date
21 May 2019
Primary completion date
31 May 2025
Lead sponsor
Seattle Institute for Biomedical and Clinical Research
Diseases
HIV, COPD
NCT number
NCT03856879

What you commit to

  • Study type: Interventional
  • Participants enrolled: 270
  • From 21 May 2019 to the primary completion date, 31 May 2025
  • 7 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Significant cognitive dysfunction, language barriers or severe psychiatric disorder, impairing ability to participate in surveys and interviews.

Other

  • Providers:
  • Trainees
    • Patients:

Who the study is looking for

  • Providers:
  • Outpatient infectious disease providers at one of the seven local sites participating in this study.
    • Patients:
  • HIV+ patients with COPD treated by providers enrolled in the study.

Age in the registry: 18 years to 89 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (7)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Atlanta VA Health Care System
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
VA Eastern Colorado Health Care System
Coordinator of this site? Confirm its status
DenverUnited StatesUnknown status
VA Greater Los Angeles Healthcare System
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
Nashville VA Medical Center
Coordinator of this site? Confirm its status
NashvilleUnited StatesUnknown status
VA Connecticut Healthcare System
Coordinator of this site? Confirm its status
New HavenUnited StatesUnknown status
Philadelphia VA Medical Center
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
Washington DC VA Medical Center
Coordinator of this site? Confirm its status
Washington D.C.United StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.